History | Coexisting severe mental illness and substance misuse: community health and social care services | Guidance | NICE

Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
View all What we do
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

History

Consultation comments published

Consultation comments and responses (PDF 2.41 MB)

Published:

30 November 2016

Equality and health inequalities assessment

Equality impact assessment (PDF 208 KB)

Published:

30 November 2016

Draft guidance consultation

Draft guidance consultation
Draft guideline (PDF 405 KB)

Published:

12 May 2016
Equality impact assessment (PDF 92 KB)

Published:

12 May 2016
Committee member list (PDF 250 KB)

Published:

12 May 2016
Expert report 1 (PDF 83 KB)

Published:

12 May 2016
Expert report 2 (PDF 345 KB)

Published:

12 May 2016
Expert report 3 (PDF 376 KB)

Published:

12 May 2016
Expert report 4 (PDF 174 KB)

Published:

12 May 2016
Expert report 5 (PDF 88 KB)

Published:

12 May 2016
Evidence review 1 (PDF 2.1 MB)

Published:

12 May 2016
Evidence review 2 (PDF 1.37 MB)

Published:

12 May 2016
Evidence review 2 Appendix 13 (PDF 230 KB)

Published:

12 May 2016
Evidence review 2 Appendix 14 (PDF 286 KB)

Published:

12 May 2016
Evidence review 2 Appendix 15 (PDF 293 KB)

Published:

12 May 2016
Evidence review 2 Appendix 16 (PDF 161 KB)

Published:

12 May 2016
Evidence review 3 (PDF 992 KB)

Published:

12 May 2016
Evidence review 3 Appendix 10 (PDF 599 KB)

Published:

12 May 2016
Evidence review 3 Appendix 11 (PDF 525 KB)

Published:

12 May 2016
Evidence review 4 (PDF 1.33 MB)

Published:

12 May 2016
Confidentiality form (PDF 105 KB)

Published:

16 May 2016
Comments form (MSWord 92 KB)

Published:

17 May 2016

Stakeholder list updated

Stakeholder list (PDF 44 KB)

Published:

12 May 2016

Review questions document published

Review protocols (PDF 435 KB)

Published:

01 March 2016
Economic plan (PDF 92 KB)

Published:

01 March 2016

Committee list updated

Committee member list (PDF 262 KB)

Published:

30 November 2016

Committee meetings

Committee meeting
Minutes from meeting 1: 30 June 2015 (PDF 232 KB)

Published:

30 November 2015
Minutes from meeting 2: 22 September 2015 (PDF 250 KB)

Published:

30 November 2015
Minutes from meeting 3: 3 November 2015 (PDF 255 KB)

Published:

14 January 2016
Minutes from meeting 4: 8 December 2015 (PDF 275 KB)

Published:

12 February 2016
Minutes from meeting 5&6 1 and 2 February 2016 (PDF 268 KB)

Published:

14 October 2016
Minutes from meeting 7&8: 18 and 19 July 2016 (PDF 253 KB)

Published:

14 October 2016

Draft scope consultation

Draft scope consultation
Draft scope (PDF 206 KB)

Published:

28 October 2014

Call for evidence

Call for evidence information

Draft scope external stakeholder comments and responses

Draft scope external stakeholder comments and responses
Draft scope external stakeholder comments and responses (PDF 1.09 MB)

Published:

22 January 2015

Final scope

Final scope
Final scope (PDF 274 KB)

Published:

22 January 2015

Equality impact assessment - scoping

Equality impact assessment - scoping
Equality impact assessment - scoping (PDF 89 KB)

Published:

22 January 2015